NERVE DAMAGE-TREATING AGENT AND NERVE DAMAGE-TREATING METHOD

摘要

PPROBLEM TO BE SOLVED: To specify a target disease for which iPS cells can be used. PSOLUTION: Differentiation cell-originated pluripotent stem cells obtained by forcibly expressing an initialized gene such as the combination of Oct3/4 gene, Sox2 gene, Klf4 gene, and c-myc gene with differentiation cells, or cells obtained by differentiating and inducing the differentiation cell-originated pluripotent stem cells with embryoid bodies or neurospheres are administered to a patient having a nerve damage. PCOPYRIGHT: (C)2009,JPO&INPIT